Castile and León Invests €1.8 Million in Vaccines for 2024-2025
Castilla y León Invests Nearly $2 Million in Vaccines for 2024-2025
Madrid, Spain - December 15, 2024 – The Castilla y León regional government has approved a €1.8 million investment to purchase 125,150 vaccine doses for the 2024-2025 period. This crucial investment will ensure the continued protection of the region’s population against preventable diseases.
The purchase, made in accordance with an agreement with the Spanish Ministry of Health, covers a range of essential vaccines.
“This investment demonstrates our commitment to public health and the well-being of all Castilla y León residents,” said [Insert Name and Title of Relevant official]. “By ensuring access to these vital vaccines, we are taking proactive steps to prevent the spread of serious diseases.”
The vaccine allocation includes:
60,000 doses against diphtheria and tetanus for individuals aged 14 to 65. 15,000 doses of the hepatitis B vaccine for adults with risk factors, including healthcare workers and international travelers.
1,700 doses of the hepatitis B vaccine for specific groups, such as immunocompromised individuals, those undergoing dialysis, and pre-dialysis patients. 1,450 doses of the hepatitis A vaccine for children in situations of potential exposure, such as travel to endemic areas or contact with infected individuals.
15,000 doses of the hepatitis A vaccine for adults who have been exposed to the virus through similar circumstances.
32,000 doses of the varicella vaccine for children aged 15 months, as well as for unvaccinated 12-year-olds and adults who haven’t had the disease.
This investment underscores Castilla y León‘s dedication to safeguarding public health and ensuring the availability of essential preventative measures for its citizens.
Castilla y León Prioritizes public Health with €1.8 Million Vaccine Investment
Madrid, Spain – december 15, 2024 – In a move highlighting its commitment to public health, the Castilla y León regional government has announced a critically important investment of €1.8 million to secure 125,150 vaccine doses for the 2024-2025 period.
This crucial acquisition, made in collaboration with the Spanish Ministry of health, covers a range of essential vaccines aimed at protecting residents from preventable diseases.
“[Insert Name and Title of Relevant official],” emphasized the regional government’s dedication to the well-being of its citizens. “This investment underscores our proactive approach to preventing the spread of serious diseases and ensuring the continued health of all Castilians and Leoneses.”
The vaccine allocation will address a variety of needs,including:
Diphtheria and Tetanus: 60,000 doses will be allocated for individuals aged 14 to 65.
Hepatitis B:
15,000 doses will be designated for adults with risk factors, encompassing healthcare workers and international travelers.
An additional 1,700 doses will target specific groups such as immunocompromised individuals,dialysis patients,and pre-dialysis patients.
Hepatitis A:
1,450 doses will protect children in situations of potential exposure, including travel to endemic areas or contact with infected individuals.
Hepatitis A (Adults): 15,000 doses will be available for adults exposed to the virus.
varicella (Chickenpox): 32,000 doses will be administered to children aged 15 months, and also unvaccinated 12-year-olds and adults who have not had chickenpox.
This significant investment underlines Castilla y León’s unwavering commitment to safeguarding public health and ensuring access to vital preventative measures for its citizens.